(6-溴萘-2-基氧基)-叔丁基二甲基硅烷 | 100751-65-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: (6-溴萘-2-基氧基)-叔丁基二甲基硅烷
• 英文名称: (6-bromonaphthalen-2-yloxy)-tert-butyldimethylsilane
• 英文别名: 2-(T-Butyldimethylsilyloxy)-6-bromonaphthalene；(6-bromonaphthalen-2-yl)oxy-tert-butyl-dimethylsilane
• CAS: 100751-65-3
• 化学式: C₁₆H₂₁BrOSi
• 分子量: 337.332
• InChiKey: SSFFBVWGOVGZJB-UHFFFAOYSA-N

物化性质

• 熔点：
  61-64 °C
• 沸点：
  354.6±15.0 °C(Predicted)
• 密度：
  1.195±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.99
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(t-Butyldimethylsilyloxy)-6-bromonaphthalene
Synonyms: (6-Bromonaphthalen-2-yloxy)(t-butyl)dimethylsilane

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(t-Butyldimethylsilyloxy)-6-bromonaphthalene
CAS number: 100751-65-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
No data
Boiling point:
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C16H21BrOSi
Molecular weight: 337.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (6-溴萘-2-基氧基)-叔丁基二甲基硅烷 在 吡啶 、 正丁基锂 、 四丁基氟化铵 作用下， 以 四氢呋喃 为溶剂， 反应 3.16h， 生成 6-[1-hydroxy-2-methyl-1-(1-trityl-1H-imidazol-4-yl)propyl]-2-naphthyl trifluoromethanesulfonate
  参考文献：
  名称：

  17,20-Lyase inhibitors. Part 4: Design, synthesis and structure–activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitors

  摘要：

  A novel series of naphthylmethylimidazole derivatives and related compounds have been investigated as selective 17,20-lyase inhibitors. Optimization of the substituent at the 6-position on the naphthalene ring was performed to yield a methylcarbamoyl derivative, which exhibited potent inhibitory activity against human 17,20-lyase and promising selectivity (> 200-fold) for 17,20-lyase over CYP3A4. Further modifications of the methylcarbamoyl derivative led to the discovery of the corresponding tricyclic compound, which showed highly potent activity against human 17,20-lyase (IC50 19 nM) and good selectivity (> 1000-fold) for inhibition of 17,20-lyase over CYP3A4. Additional biological evaluation revealed that the tricyclic compound had potent in vivo efficacy in monkeys and favorable pharmacokinetic profiles when administered in rats. Asymmetric synthesis of the selective tricyclic inhibitor was also achieved using a chiral alpha-hydroxy ketone. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.01.017
• 作为产物：
  描述：

  6-溴-2-萘酚 、 叔丁基二甲基氯硅烷 在 咪唑 作用下， 以74%的产率得到(6-溴萘-2-基氧基)-叔丁基二甲基硅烷
  参考文献：
  名称：

  通过C–O键激活的镍催化的甲硅烷氧基芳烃的胺化反应

  摘要：

  在苯胺衍生物的合成中，甲硅烷氧基芳烃被用作与胺的亲电子偶联伴侣。使用了多种胺底物，包括环状或无环仲胺，仲苯胺和位阻伯苯胺。另外，使用了一系列空间受阻和不受阻碍的伯脂族伯胺，这些伯胺以前对其他种类的芳基醚亲电试剂具有挑战性。举例说明了甲硅烷基氧芳烃与芳基甲基醚的正交偶联，其中两个C-O亲电试剂之间的选择性由配体控制确定，从而使任一亲电试剂实现互补和选择性的后期多样化。最后，

  DOI：

  10.1002/anie.201806790

文献信息

• [EN] BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS<br/>[FR] ANALOGUES D’ARYLSPHINGOSINE-1-PHOSPHATE BICYCLIQUES
  申请人：BIOGEN IDEC INC

  公开号：WO2011017561A1

  公开（公告）日：2011-02-10

  Compounds that have agonist activity at one or more of the SlP receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at SlP receptors.

  提供具有在一个或多个SlP受体上拮抗活性的化合物。这些化合物是鞘氨醇类似物，在磷酸化后可以在SlP受体上表现为拮抗剂。
• Substituted phenyl naphthalenes as estrogenic agents
  申请人：Wyeth

  公开号：US20030181519A1

  公开（公告）日：2003-09-25

  This invention provides estrogen receptor modulators of formula I, having the structure 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 , are as defined in the specification, or a pharmaceutically acceptable salt thereof.

  这项发明提供了具有结构的式I的雌激素受体调节剂 1 其中 R 1 ，R 2 ，R 3 ，R 4 ，R 5 ，R 6 ，R 7 ，R 8 ，R 9 和R 10 如规范中所定义，或其药用可接受盐。
• Nickel‐Catalyzed Amination of Silyloxyarenes through C–O Bond Activation
  作者：Eric M. Wiensch、John Montgomery

  DOI：10.1002/anie.201806790

  日期：2018.8.20

  Silyloxyarenes were utilized as electrophilic coupling partners with amines in the synthesis of aniline derivatives. A diverse range of amine substrates were used, including cyclic or acyclic secondary amines, secondary anilines, and sterically hindered primary anilines. Additionally, a range of sterically hindered and unhindered primary aliphatic amines were employed, which have previously been challenging with

  在苯胺衍生物的合成中，甲硅烷氧基芳烃被用作与胺的亲电子偶联伴侣。使用了多种胺底物，包括环状或无环仲胺，仲苯胺和位阻伯苯胺。另外，使用了一系列空间受阻和不受阻碍的伯脂族伯胺，这些伯胺以前对其他种类的芳基醚亲电试剂具有挑战性。举例说明了甲硅烷基氧芳烃与芳基甲基醚的正交偶联，其中两个C-O亲电试剂之间的选择性由配体控制确定，从而使任一亲电试剂实现互补和选择性的后期多样化。最后，
• Pharmaceutical compounds
  申请人：——

  公开号：US20040122001A1

  公开（公告）日：2004-06-24

  This invention relates to compounds of formula (I) where R 1 to R 12 , —W—V—, —X—Y—, m and n have the values defined in claim 1, their preparation and use as pharmaceuticals. 1

  这项发明涉及到式(I)的化合物，其中R1至R12，—W—V—，—X—Y—，m和n的值如权利要求1中定义的，它们的制备和用作药物。
• Rhodium-Catalyzed Remote Isomerization of Alkenyl Alcohols to Ketones
  作者：Wenke Dong、Hongxuan Yang、Wen Yang、Wanxiang Zhao

  DOI：10.1021/acs.orglett.9b04508

  日期：2020.2.21

  We develop herein an efficient rhodium-catalyzed remote isomerization of aromatic and aliphatic alkenyl alcohols into ketones. This catalytic process, with a commercially available catalyst and ligand ([RhCl(cod)]2 and Xantphos), features high efficiency, low catalyst loading, good functional group tolerance, a broad substrate scope, and no (sub)stoichiometric additive. Preliminary mechanistic studies

  我们在本文中开发了一种有效的铑催化的芳族和脂族烯基醇远程异构化成酮的方法。该催化过程使用市售的催化剂和配体（[RhCl（cod）] 2和Xantphos），具有效率高，催化剂用量低，官能团耐受性好，底物范围宽和无（亚）化学计量添加剂的特点。初步的机理研究表明，这种转变涉及迭代解离的β-氢化物消除-迁移插入过程。